Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

107.86USD
21 Nov 2014
Price Change (% chg)

$0.38 (+0.35%)
Prev Close
$108.18
Open
$108.63
Day's High
$108.65
Day's Low
$107.62
Volume
3,290,952
Avg. Vol
2,240,719
52-wk High
$109.49
52-wk Low
$86.09

JNJ.N

Chart for JNJ.N

About

Johnson & Johnson is a holding company engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products in virtually all... (more)

Overall

Beta: 0.56
Market Cap (Mil.): $302,807.81
Shares Outstanding (Mil.): 2,799.11
Dividend: 0.70
Yield (%): 2.59

Financials

  JNJ.N Industry Sector
P/E (TTM): 17.91 38.05 39.20
EPS (TTM): 6.04 -- --
ROI: 16.48 17.86 17.16
ROE: 23.66 18.61 18.09
Search Stocks

RPT-J&J seeks over $5 bln in damages from Boston Scientific at trial

NEW YORK, Nov 19 - Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp , Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.

19 Nov 2014

BRIEF-Raisio acquired Benecol business from affiliates of Johnson & Johnson

* Has acquired Benecol business from affiliates of Johnson & Johnson

19 Nov 2014

J&J seeks over $5 billion in damages from Boston Scientific at trial

NEW YORK - Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.

19 Nov 2014

J&J seeks over $5 bln in damages from Boston Scientific at trial

NEW YORK, Nov 19 - Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp , Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.

19 Nov 2014

US STOCKS-Wall St flat after retail sales, UMich data

* Indexes: Dow off 0.01 pct, S&P up 0.05 pct, Nasdaq up 0.07 pct (Adds UMich data, Virgin America IPO)

14 Nov 2014

US STOCKS-Wall St opens flat after retail sales, UMich data on tap

* Indexes: Dow off 0.04 pct, S&P flat, Nasdaq off 0.11 pct (Updates to market open)

14 Nov 2014

US STOCKS-Wall St to open flat after retail sales, UMich data due

* Futures up: Dow 7 pts, S&P 0.5 pt, Nasdaq 0.75 pt (Adds data, updates prices)

14 Nov 2014

US STOCKS-Futures flat ahead of retail sales, UMich data

* Futures up: Dow 11 pts, S&P 1.5 pt, Nasdaq 2.75 pts (Adds premarket actives)

14 Nov 2014

US STOCKS-Futures little changed ahead of data

NEW YORK, Nov 14 - U.S. stock index futures were little changed on Friday, with the S&P on track for a fourth straight weekly advance, ahead of data on consumer sentiment.

14 Nov 2014

Geron sells last drug in pipeline to J&J unit

- Geron Corp licensed its cancer compound, the last in its pipeline, to a unit of Johnson & Johnson for up to $935 million, sending its shares up as much as 33 percent in extended trading.

14 Nov 2014

Earnings vs. Estimates

Search Stocks